P4HA3 and non-small cell lung carcinoma: Next, we analyzed the expression of P4HA3 in NSCLC clinical samples in three independent studies (GSE3141, GSE30219, and GSE31210)36–38, which revealed a significant positive correlation (P < 0.05) between P4HA3 expression and poor prognosis (Fig. 6a).